Back to Search
Start Over
Real-world (RW) experience with atezolizumab + bevacizumab (A+B) for the treatment of unresectable HCC (uHCC): A multicenter study.
- Source :
- Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p537-537, 132p
- Publication Year :
- 2025
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 43
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 182479229
- Full Text :
- https://doi.org/10.1200/JCO.2025.43.4_suppl.537